Postnatal iron overload destroys NA-DA functional interactions

Journal of Neural Transmission

Volumn 114, Issue 2, 2007, Pages 195-203

  Fredriksson, A ^a   Archer, T ^b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LINNAEUS UNIVERSITY   (Sweden)

Author keywords

C57 BL6 mice; Clonidine; DA; Denervation; DSP4; Locomotion; Motor deficits; MPTP; NA; PD; Postnatal iron; Rearing; Restoration; Subthreshold L Dopa; Suprathreshold L Dopa; Total activity; Vehicle

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 BROMO N (2 CHLOROETHYL) N ETHYLBENZYLAMINE; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; DOPAMINE; IRON; LEVODOPA; NORADRENALIN; SODIUM CHLORIDE; ZIMELDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRADYKINESIA; CONTROLLED STUDY; DISEASE EXACERBATION; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; HABITUATION; IRON OVERLOAD; LOCOMOTION; MALE; MOLECULAR INTERACTION; MOTOR ACTIVITY; MOUSE; NEWBORN; NONHUMAN; NORADRENERGIC SYSTEM; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REARING;

ADRENERGIC AGENTS; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; BENZYLAMINES; CLONIDINE; CORPUS STRIATUM; DENERVATION; DOPAMINE; DOPAMINE AGENTS; IRON OVERLOAD; LEVODOPA; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; NOREPINEPHRINE;

EID: 33846410749     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-006-0522-6     Document Type: Article

References (40)

1. T Archer 1982 Serotonin and fear retention in the rat J Comp Physiol Psychol 96 491 516
2. T Archer A Fredriksson 2000 Effects of clonidine and adrenoceptor antagonists on motor activity in DSP4-treated mice I: dose, time- and parameter-dependency Neurotoxicity Res 1 235 247
3. T Archer A Fredriksson 2001 Effects of α-adrenoceptor agonists in chronic morphine administered DSP4-treated rats: evidence for functional cross-sensitization Neurotoxicity Res 3 411 432
4. T Archer A Fredriksson 2003 An antihypokinesic action of α2-adrenoceptors upon MPTP-induced behaviour deficits in mice J Neural Transm 110 183 200
5. Archer T, Fredriksson A (2006) Influence of noradrenaline denervation on MPTP-induced deficits in mice. J Neural Transm (in press)
6. T Archer S-O Ögren G Johansson SB Ross 1982 DSP4-induced two-way active avoidance impairment: involvement of central and not peripheral noradrenaline depletion Psychopharmacology 76 303 309
7. T Archer AK Mohammed SB Ross U Söderberg 1983 T-maze learning, spontaneous activity and food intake recovery following systemic administration of the noradrenaline neurotoxin, DSP4 Pharmacol Biochem Behav 19 121 130
8. T Archer G Jonsson SB Ross 1984 A parametric study of the effects of the noradrenaline neurotoxin DSP4 on avoidance acquisition and noradrenaline neurons in the CNS of the rat Br J Pharmacol 82 249 257
9. T Archer G Jonsson SB Ross 1985 Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine Behav Neural Biol 43 238 249
10. T Archer A Fredriksson G Jonsson T Lewander AK Mohammed SB Ross U Soderberg 1986a Central noradrenaline depletion antagonizes aspects of d-amphetamine-induced hyperactivity in the rat Psychopharmacology 88 141 146
11. T Archer G Jonsson BG Minor C Post 1986b Noradrenergic-serotonergic interactions and nociception in the rat Europ J Pharmacol 120 295 307
12. DJ Dooley H Bittiger KL Hauser SL Bischoff PC Waldmeier 1983a Alteration of central alpha 2- and beta-adrenergic receptors in the rat after DSP4, a selective noradrenergic neurotoxin Neuroscience 9 889 898
13. DJ Dooley E Mogilnicka A Delini-Stula F Waechter A Truog J Wood 1983b Functional supersensitivity to adrenergic agonists in the rat after DSP-4, a selective noradrenergic neurotoxin Psychopharmacology 81 1 5
14. F Fornai L Bassi MT Torracca MG Alessandri V Scalori GU Corsini 1996 Region- and neurotransmitter-dependent species and strain differences in DSP4-induced monoamine depletion in rodents Neurodegeneration 5 241 249
15. F Fornai MG Alessandri MT Torracca L Bassi GU Corsini 1997 Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions J Pharmacol Exp Ther 283 100 107
16. A Fredriksson T Archer 1994 MPTP-induced behavioural and biochemi_cal deficits: a parametric analysis J Neural Transm Park Dis Dement Sect 7 123 132
17. A Fredriksson T Archer 2000 Effects of clonidine and α-adrenoceptor antagonists on motor activity in DSP4-treated mice II: interactions with apomorphine Neurotoxicity Res 1 249 259
18. A Fredriksson T Archer 2003 Effect of postnatal iron administration on MPTP-induced behavioural deficits and neurotoxicity: behavioural enhancement by L-Dopa-MK-801 co-administration Behav Brain Res 139 31 46
19. A Fredriksson A Plaznik E Sundström G Jonsson T Archer 1990 MPTP-induced hypoactivity in mice: reversal by L-Dopa Pharmacol Toxicol 67 295 301
20. A Fredriksson T Palomo TN Chase T Archer 1999 Tolerance to a suprathreshold dose of L-Dopa in MPTP mice: effects of glutamate antagonists J Neural Transm 106 283 300
21. A Fredriksson N Schroder P Eriksson I Izquierdo T Archer 2001 Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits Parkinsonism Relat D 7 97 105
22. J Glowinski LL Iversen 1966 Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain J Neurochem 13 655 669
23. DJ Heal SA Butler MR Prow WR Buckett 1993 Quantification of alpha 2-adrenoceptors in rat brain after short-term DSP-4 lesioning Europ J Pharmacol 249 37 41
24. RE Heikkila B-A Sieber L Manzino PK Sonsalla 1989 Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in the mouse Mol Chem Neuropathol 10 171 183
25. G Jonsson H Hallman 1982 Response of central monoamine neurons following an early neurotoxic lesion Bibl Anat 23 76 92
26. G Jonsson H Hallman F Ponzio SB Ross 1981 DSP4 (N-(2-chloroethyl)-N- ethyl-2-bromobenzylamine) - a useful denervation tool for central and peripheral noradrenaline neurons Europ J Pharmacol 72 173 188
27. G Jonsson H Hallman E Sundström 1982 Effects of the noradrenaline neurotoxin DSP4 on the postnatal development of central noradrenaline neurons in the rat Neuroscience 7 2895 2907
28. R Kirk 1995 Experimental design: procedures for the behavioural sciences Brooks/Cole Belmont, Calif
29. JW Langston 1985 MPTP neurotoxicity: an overview and characterization of phases of toxicity Life Sci 36 201 206
30. AJ Latigan MR Marien FC Colpaert 1992 Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study Life Sci 50 995 999
31. MR Marien M Briley FC Colpaert 1993 Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice Europ J Pharmacol 236 487 489
32. MR Marien FC Colpaert AC Rosenquist 2004 Noradrenergic mechanisms in neurodegenerative diseases: a theory Brain Res Rev 45 38 78
33. K Nishi T Kondo H Narabayashi 1991 Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by L-dopa Neurosci Lett 123 244 247
34. F Ponzio H Hallman G Jonsson 1981 Noradrenaline and dopamine interaction in rat brain during development Med Biol 59 161 169
35. C Post ML Persson T Archer BG Minor W Danysz E Sundström 1987 Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion Europ J Pharmacol 137 107 116
36. M Riekkinen K Kejonen 1998 Reduction of noradrenaline impairs attention and dopamine depletion slows response in Parkinson's disease Europ J Neurosci 10 1429 1435
37. SB Ross 1976 Long-term effects of N-2-chloroethyl-N-ethyl-2- bromobenzylamine hydrochloride on noradrenergic neurons in the rat brain and heart Brit J Pharmacol 58 521 527
38. SB Ross L Renyi 1976 On the long-lasting inhibitory effect of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP4) on the active uptake of noradrenaline J Pharmacol Pharmac 28 458 459
39. PK Sonsalla RE Heikkila 1986 The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice Europ J Pharmacol 129 339 345
40. E Sundström A Fredriksson T Archer 1990 Chronic neurochemical and behavioural changes in MPTP-lesioned C57 Bl/6 mice: a model for Parkinson's disease Brain Res 528 181 188